Health & Science

Home Health & Science

Karoline Leavitt Prepares For Second Child As White House Weighs Temporary Shift

Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons


White House press secretary Karoline Leavitt is expected to welcome her second child this week, adding a personal milestone to a tenure already defined by firsts. At 28, she is the youngest press secretary in U.S. history and the first known to serve in the role while pregnant.

Her upcoming leave raises practical questions for the administration, including how long she plans to step away and how the White House will manage one of its most visible daily responsibilities in her absence.

Unclear timeline for leave

A White House official said it’s not yet clear how much time Leavitt will take off after the birth. Like other federal employees, she is generally entitled to up to 12 weeks of paid parental leave. Whether she uses the full period remains an open question.

That uncertainty leaves the briefing schedule in a flexible position, with no firm timeline for her return to the podium.

No interim press secretary planned

Instead of naming a temporary replacement, the White House plans to rely on a rotating group of officials to handle press briefings. That group could include President Donald Trump and Vice President JD Vance, an approach that would break from the more traditional model of a single, consistent spokesperson.

The decision signals a willingness to experiment, but it also introduces the possibility of mixed messaging. Different officials bring different styles, and consistency has long been a priority in managing daily communication with the press.

Family life in the public eye

Leavitt first announced her pregnancy in December, sharing that she and her husband, Nicholas Riccio, were expecting a daughter. Their first child, Niko, was born in July 2024 and has already appeared in the briefing room during special events.

In a social media post after Christmas, Leavitt said she was looking forward to becoming a “girl mom” and described the coming year as meaningful for her family. She also pointed to what she called a supportive, pro-family culture within the White House, crediting both President Trump and chief of staff Susie Wiles.

Staying active on the job

Leavitt continued her duties throughout the pregnancy, rarely stepping back from the demands of the role. That includes leading daily briefings and serving as a central voice for the administration during a busy stretch of domestic and international developments.

Her tenure has also brought changes to the structure of the briefing room. Most notably, she introduced a designated space for “new media,” giving podcasters, independent journalists, and digital creators a more visible presence.

She has often called on those voices early in briefings, a shift away from the traditional dominance of legacy outlets.

A test for a changing briefing room

Leavitt’s temporary absence could put that evolving setup to the test. With multiple officials rotating through the podium, the tone and priorities of briefings may shift from day to day.

That variability may not matter much during quieter periods. But in moments that require clear, unified messaging, it could become more noticeable.

Balancing public service and private life

For now, the focus remains on a personal milestone. Even in a role tied closely to national politics and constant scrutiny, family life continues alongside the job.

Leavitt’s situation underscores a familiar challenge in Washington: balancing the demands of public service with life outside the office. It’s not unique, but it’s rarely this visible.

Her return, whenever it comes, will likely bring the operation back to a more familiar rhythm. Until then, the White House is preparing to adjust on the fly.

READ NEXT: Major City Removes Leader Following Appalling Lawsuit

White House Addresses Trump Health After Viral Photos Spark Speculation

By The White House - https://www.flickr.com/photos/202101414@N05/54581054338/, Public Domain,

White House press secretary Karoline Leavitt addressed concerns over President Donald Trump’s health during a briefing on Thursday after photographs of his hand appearing bruised and his ankles appearing swollen went viral.

“I know that many in the media have been speculating about bruising on the president’s hand, and also swelling in the president’s legs. So in the effort of transparency, the president wanted me to share a note from his physician with all of you today,” began Leavitt before reading from the note:

In recent weeks, President Trump noted mild swelling in his lower legs. In keeping with routine medical care and out of an abundance of caution, this concern was thoroughly evaluated by the White House Medical Unit. The president underwent a comprehensive examination, including diagnostic vascular studies. Bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70.

Importantly, there was no evidence of deep vein thrombosis or arterial disease. Laboratory testing included a complete blood count, comprehensive metabolic panel, coagulation profile, D-dimer, B-type, natriotic, peptide, and cardiac biomarkers. All results were within normal limits. An echocardiogram was also performed, and confirmed normal cardiac structure and function. No signs of heart failure, renal impairment, or systemic illness were identified.

Additionally, recent photos of the president have shown minor bruising on the back of his hand. This is consistent with minor soft tissue irritation from frequent handshaking, and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen. This is a well-known and benign side effect of aspirin therapy, and the president remains in excellent health.

“Which I think all of you witness on a daily basis here,” added Leavitt. “So the president wanted me to share that note with all of you. I’m happy to take further questions on it. We will provide the memorandum from the president’s physician to all of you, as we always do.

Watch:

‘Abandoned A Viable Path’: White House Abruptly Pulls FDA Nominee As MAHA Grassroots Clash With Cassidy

AI-generated image.

WASHINGTON — Hours before a scheduled Senate committee vote, the White House abruptly pulled Dr. Heidi Overton’s nomination to lead the Food and Drug Administration late Tuesday night — sparking immediate celebrations from Make America Healthy Again activists while drawing a sharp public rebuke from Senate Health Committee Chairman Bill Cassidy, R-La.

Overton, a Johns Hopkins-trained physician and deputy director of the White House Domestic Policy Council, had been scheduled for a Wednesday morning confirmation vote before the Senate Health, Education, Labor, and Pensions (HELP) Committee. With Republicans holding only a razor-thin one-vote majority on the panel — and moderate GOP Sens. Susan Collins of Maine and Lisa Murkowski of Alaska still uncommitted — administration officials concluded she lacked the votes to advance.

Cassidy Blasts White House Over Pro-Life Standoff

The withdrawal triggered an extraordinary public clash with Sen. Cassidy, who had originally criticized Overton’s appointment in August as “almost disqualifying” over her support for breaking up combination childhood vaccines. Having since warmed to Overton — viewing her as a steadying counterbalance to Health and Human Services Secretary Robert F. Kennedy Jr. — Cassidy accused the White House of pulling the plug rather than giving pro-life senators firm assurances on restricting the abortion pill mifepristone.

“Tonight, the White House abandoned a viable confirmation path for Dr. Overton. … My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk. The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues. The Administration withdrew Dr. Overton rather than make such commitments.” — Sen. Bill Cassidy (R-La.), Senate HELP Committee Chairman

MAHA Activists Claim Victory As Clock Runs Out

While Cassidy lamented that confirming a permanent FDA chief will now fall to incoming Senate Democrats in January, grassroots leaders aligned with Secretary Kennedy’s MAHA coalition celebrated Overton’s exit as a decisive win against establishment and pharmaceutical industry influence.

Activists had targeted Overton for weeks over concerns she was too accommodating toward Big Pharma and agricultural chemical interests, while former Kennedy aide Calley Means charged that entrenched officials inside the administration had worked “at the behest of industry lobbyists”. Conservative wellness host Alex Clark likewise credited MAHA pressure for derailing a nominee seen as insufficiently committed to Kennedy’s overhaul of chronic disease and food safety regulations.

With the GOP’s Senate majority expiring in weeks, administration officials have begun weighing alternative paths—including tapping outgoing Kansas Sen. Roger Marshall, a conservative physician and OB-GYN who lost his reelection bid earlier this month, or relying on acting leadership to keep Secretary Kennedy’s reform agenda moving forward without handing Senate Democrats a veto.

READ NEXT: The Real Story Behind The 90-Day Blackout Headlines

Giuliani Leaves Hospital ICU In Latest Health Update

(Nova York - EUA, 24/09/2019) Presidente da República, Jair Bolsonaro, durante encontro com o senhor Rudolph Giuliani, ex-prefeito da cidade de Nova York. .Foto: Alan Santos/PR

Former New York City Mayor Rudy Giuliani has reportedly left the intensive care unit, according to his spokesperson, after being hospitalized with pneumonia.

Giuliani “will spend some time recovering before leaving the hospital,” spokesperson Ted Goodman said in a statement, adding: “The mayor and his family appreciate the outpouring of love and prayers sent his way.”

Giuliani had been hospitalized in critical condition earlier this week, his spokesperson said Sunday.

Dr. Maria Ryan told Fox News that Giuliani’s condition had deteriorated rapidly after he returned from a trip to Paris, with severe breathing issues forcing doctors to place him on a ventilator. At one point, his situation became so dire that a priest was called to administer last rites.

But by Tuesday, everything changed.

“He’s a fighter — the way he was yesterday in such a critical condition, he did have a priest come anoint him,” Ryan said. “And all the prayers from around — it’s like a miracle. This guy’s got 9 lives, today he’s doing much better.”

Goodman said Giuliani was previously diagnosed with restrictive airway disease, which he said was a result of his proximity to the collapsed World Trade Center towers on Sept. 11, 2001. 

“This condition adds complications to any respiratory illness, and the virus quickly overwhelmed his body, requiring mechanical ventilation to maintain adequate oxygen and stabilize his condition,” Goodman said Monday. 

MAHA Year One: How Trump & RFK Jr. Are Rebuilding American Health

1
By Gage Skidmore from Surprise, AZ, United States of America - Robert F. Kennedy, Jr., CC BY-SA 2.0,

For decades, Americans were told a story about their health that no longer matched reality. We were assured that food was safe, that regulators were vigilant, that medical advice was insulated from politics and profit, and that rising chronic disease was an unfortunate but unavoidable byproduct of modern life. Meanwhile, the health of the nation deteriorated in plain sight. Obesity climbed year after year. Childhood chronic disease became common rather than exceptional. Autism rates surged. Cancer diagnoses among children rose. By the time President Trump returned to office, 76.4% of Americans were living with at least one chronic disease. Eight out of 10 children could not qualify for military service. What should have been treated as a civilizational emergency was instead normalized, until that long-running failure of honesty and accountability culminated during the COVID-19 pandemic, when public health leaders abandoned transparency, misled the public, and, under Dr. Fauci’s direction, shattered trust in medical professionals and the institutions meant to serve them.

The collapse of trust that followed COVID did not occur in a vacuum. It was the culmination of years of regulatory capture, scientific arrogance, and a public health establishment that confused authority with truth. Americans were ordered, not persuaded. Dissent was pathologized. Data was selectively presented. Vaccine policy was enforced through mandate rather than transparency. Dr. Fauci became the symbol of an anti-science regime that claimed infallibility while revising its claims in real time. When institutions insist on obedience while refusing accountability, trust does not merely erode; it implodes.

It is against this backdrop that the Make America Healthy Again initiative must be understood. MAHA is not a branding exercise or a partisan slogan. It is a course correction. President Trump’s decision to place Robert F. Kennedy Jr. at the helm of HHS was not an appeal to nostalgia or name recognition. It was an explicit rejection of the managerial consensus that presided over the chronic disease explosion. The mandate was simple and radical: identify root causes, dismantle regulatory capture, and tell the truth even when it disrupts powerful interests.

Skeptics ask whether one year can matter. The answer depends on what one expects a first year to do. MAHA was never going to reverse decades of metabolic, environmental, and institutional decay overnight. Its purpose was to reorient the system, establish credibility, and force long-delayed questions back into the open. By that standard, the first year has been historic.

Start with the scope of institutional change. President Trump signed an executive order establishing the MAHA Commission, chaired by Secretary Kennedy, with a singular focus on chronic disease. For the first time in generations, chronic illness was treated not as an actuarial inevitability but as a policy failure demanding investigation. This alone marked a break with orthodoxy. Under previous administrations, chronic disease spending rose to $1.3T annually while prevention remained an afterthought. When Kennedy notes that the federal government once spent essentially nothing on chronic disease, he is not making a rhetorical point. He is diagnosing a structural blind spot.

The results are already visible. Thirty-seven states have enacted legislation advancing MAHA-aligned reforms. Nearly 100 MAHA-related bills have passed nationwide. Eighteen states secured SNAP waivers to restrict taxpayer-funded junk food purchases that directly fuel obesity and diabetes. These are not symbolic victories. They are structural incentives aligned with public health rather than industry convenience.

Food policy has been the most visible arena of reform, and for good reason. The American diet did not become toxic by accident. It was engineered through regulatory loopholes that allowed synthetic additives to enter the food supply under the GRAS standard with minimal oversight. MAHA moved quickly to overhaul this system. Agreements now cover roughly 40% of the food industry, committing to remove petroleum-based synthetic dyes. The dairy industry has pledged to eliminate artificial dyes from ice cream by 2028. These changes matter because they reset norms. Once voluntary reform becomes expected, resistance collapses.

The same logic applies to infant health. Operation Stork Speed was launched to expand access to safe and nutritious infant formula while removing heavy metals that had no business entering baby food in the first place. For parents who watched institutions minimize legitimate safety concerns during COVID, this shift toward precaution and transparency has been decisive in rebuilding trust.

Critics often ask whether MAHA is anti-science. The premise is backward. MAHA is anti-dogma. It insists that science earns authority through openness, replication, and humility. This is why vaccine policy has been reframed around informed consent and gold standard trials rather than mandates. Honesty about uncertainty is not weakness. It is the precondition of credibility. Public trust returns when institutions stop pretending to be omniscient.

This emphasis on trust extends beyond food and vaccines. HHS issued guidance restoring biological truth, recognizing that there are two sexes, male and female. This was not culture war theater. Medicine depends on biological reality. When institutions deny observable facts for ideological reasons, patients notice. Restoring clarity restores confidence.

MAHA’s critics also underestimate the importance of state-level experimentation. Utah’s decision to ban added fluoride in public drinking water did not impose a national mandate. It reopened a conversation that had been closed by bureaucratic inertia. Communities are once again allowed to weigh risks and benefits rather than defer to outdated consensus.

Health care delivery itself has not been ignored. Prior authorization has long functioned as a hidden tax on patients and physicians, delaying care while enriching intermediaries. Secretary Kennedy and CMS Administrator Oz secured industry commitments to streamline this process across health plans. Less paperwork means faster treatment and lower burnout. These are the reforms patients feel immediately.

Drug pricing has followed the same philosophy. President Trump’s most favored nation order is being rapidly implemented to align U.S. prescription drug prices with those paid abroad. This is not price control masquerading as populism. It is a refusal to subsidize global markets at the expense of American patients. Lower prices are a public health intervention.

Physical health has returned to the cultural mainstream as well. The Pete and Bobby Challenge, launched by Secretary Kennedy alongside Defense Secretary Hegseth, did something that countless white papers failed to do. It made fitness visible again. A nation where most children cannot meet basic physical standards is not merely unhealthy. It is vulnerable.

The MAHA Commission’s release of the Make Our Children Healthy Again strategy, outlining more than 120 initiatives, signaled that childhood chronic disease is no longer being treated as a mystery or a taboo. New data linking rising thyroid and kidney cancers among children demands answers. Autism rates demand answers. MAHA has made clear that asking these questions is not forbidden. It is required.

Perhaps the most underestimated achievement of the first year is cultural rather than regulatory. Trust is returning because institutions are speaking plainly. The public understands that special interests once thrived behind closed doors. They know they were sold better cigarettes and sugar smacks with a health halo. What they demanded in 2024 was not perfection. It was honesty.

President Trump and Secretary Kennedy have delivered the first credible attempt in decades to dismantle the alliance between bureaucratic power and corporate profit that hollowed out public health. The appointments at NIH, FDA, and CMS reflect this shift. These are not partisan enforcers. They are reformers tasked with ending capture and restoring the mission.

No serious observer should claim that the work is finished. Chronic disease did not emerge in one year, and it will not be eliminated in one term. But trajectories matter. Incentives matter. Trust matters most of all. After years in which Americans were told to comply and not question, MAHA has reopened the social contract between the public and medicine.

Public health cannot function without consent. Consent requires trust. Trust requires truth. That is the chain MAHA is rebuilding. It is why the first year matters. Not because every problem has been solved, but because the system has finally been pointed in the right direction.

If you enjoy my work, please subscribe: https://x.com/amuse.

Sponsored by the John Milton Freedom Foundation, a nonprofit dedicated to helping independent journalists overcome formidable challenges in today’s media landscape and bring crucial stories to you.

Senate Votes To Confirm Health and Human Services Secretary

3
Photo via Gage Skidmore Flickr

The U.S. Senate has confirmed Robert F. Kennedy Jr. as the next Secretary of Health and Human Services (HHS) following weeks of debate over his nomination.

Once again, Sen. Mitch McConnell (R-Ky.) stood alone as the only Republican to vote against President Trump’s nominee. McConnell opposed Tulsi Gabbard’s nomination as director of national intelligence (DNI).

The confirmation process was marked by intense scrutiny of Kennedy’s record and policy positions. The Senate Finance Committee advanced his nomination last Tuesday with a narrow 14-13 vote.

Senator Bill Cassidy (R-La.), a physician and key swing vote, played a decisive role in moving Kennedy’s nomination forward. Cassidy, who has represented Louisiana in the Senate since 2014, broke with some in his party to support the nominee.

The full Senate advanced Kennedy’s nomination on Wednesday following a successful cloture vote of 53 to 47.

During his confirmation process, Kennedy worked to distance himself from past remarks that raised doubts about vaccine safety.

Despite the controversy, he managed to secure enough backing from Republicans to push his nomination forward.

As head of HHS, Kennedy will oversee federal health policy, including responses to public health crises, health care regulations and medical research funding. His tenure is expected to bring significant policy debates, particularly regarding vaccine policy, regulatory oversight and public health initiatives.

With Kennedy now confirmed, all eyes will be on how he navigates key health policy challenges in the months ahead.

This is a breaking news story. Please check back for updates.

Trump Names New Pick To Lead FDA

1
The White House, Public domain, via Wikimedia Commons

President Donald Trump has selected Dr. Heidi Overton, a senior White House domestic policy adviser and physician, to lead the Food and Drug Administration as the agency confronts battles over vaccines, drug prices, food additives, and abortion medication.

Trump announced the nomination Wednesday, describing Overton as a trusted problem-solver who would accelerate medical innovation, lower prescription costs, and advance Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” agenda.

Overton currently serves as deputy director of the White House Domestic Policy Council, where she has helped formulate and promote several of the administration’s most consequential health initiatives.

If confirmed by the Senate, she would succeed Dr. Marty Makary, who left the agency in May after a turbulent tenure marked by internal disputes and disagreements over the direction of federal health policy.

Kyle Diamantas, who previously led the FDA’s Human Foods Program, is serving as acting commissioner.

A Physician With Deep White House Ties

Overton is a board-certified physician in public health and general preventive medicine. She earned her medical degree from the University of New Mexico School of Medicine and a doctorate in clinical investigation from the Johns Hopkins Bloomberg School of Public Health.

She previously trained as a general surgery resident at Johns Hopkins and advocated for greater price and quality transparency in health care.

During medical school, then-New Mexico Gov. Susana Martinez appointed Overton to the University of New Mexico Board of Regents, where she held voting and fiduciary responsibility for the university and its health system.

Overton first entered the Trump White House as a fellow in 2019, working in the Office of American Innovation and on the Domestic Policy Council. Between Trump’s terms, she served as chief policy officer at the America First Policy Institute and helped lead its Center for a Healthy America.

Her biography from the conservative organization emphasizes her work on health-care transparency, fentanyl, public health and policies designed to give patients greater control over medical decisions.

The appointment would place a committed administration loyalist at the head of an agency that regulates products representing roughly one-fifth of American consumer spending.

Overton Helped Shape Trump’s Health Agenda

Overton has appeared alongside Trump during major health policy announcements, including the administration’s efforts to negotiate “most favored nation” agreements with drug companies. The policy seeks to tie American prescription prices to the lower prices paid in other developed countries.

She was also involved in Trump’s controversial effort to revise the childhood vaccination schedule and separate the combined measles, mumps and rubella vaccine into three individual shots.

Major medical organizations have generally supported the combined MMR vaccine, which has been used for decades and reduces the number of clinical visits and injections required for full immunization. Critics fear that splitting the vaccine could create delays and lower vaccination rates.

Overton’s role in the policy is likely to become a focus of her Senate confirmation hearing, particularly as lawmakers question how she would handle pressure from Kennedy and other administration figures skeptical of established federal vaccine recommendations.

Trump praised Overton as a “rockstar” who would advance medical cures, innovation and lower drug prices.

Kennedy also supports the nomination, giving Overton an important ally inside the Department of Health and Human Services, which oversees the FDA.

Difficult Issues Await New Commissioner

The next FDA commissioner will inherit an unusually difficult collection of unfinished projects.

The agency continues to face pressure over its regulation of COVID-19 vaccines and other immunizations, including questions about which populations should receive updated shots and what evidence manufacturers must provide.

Medication abortion will present another immediate test. Pro-life organizations want the FDA to impose tighter restrictions on mifepristone, including limits on prescriptions issued through telehealth and pills delivered through the mail.

Overton has previously used the term “teleabortion” when discussing remote access to abortion medication, drawing concern from abortion-rights organizations that expect her to revisit the drug’s rules.

The FDA must also determine how aggressively it will regulate ultraprocessed foods, chemical additives, and synthetic dyes. Those issues are central to Kennedy’s MAHA movement but can conflict with the deregulatory approach traditionally favored by Republican lawmakers and industry groups.

Other pending questions involve flavored electronic cigarettes, peptide treatments, psychedelics, antidepressant warnings, and efforts to shorten the approval process for new drugs.

Overton would therefore have to balance three competing forces: Trump’s desire for faster approvals and lower prices, Kennedy’s campaign against corporate influence in food and medicine, and Republican demands for reduced federal regulation.

Management Experience Likely to Draw Scrutiny

Overton’s supporters point to her medical education, policy background, and proximity to presidential decision-making. They argue that she understands Trump’s priorities and can coordinate more effectively with the White House than an outside nominee.

Critics are expected to focus on her limited experience running an organization comparable to the FDA.

The agency employs thousands of scientists, physicians, inspectors, lawyers, and regulatory specialists. It oversees prescription drugs, medical devices, vaccines, tobacco products, much of the nation’s food supply, and other consumer goods.

Axios reported before her selection that some health policy observers worried Overton’s nomination could unsettle FDA career employees and pharmaceutical investors, while other potential candidates possessed more direct executive management experience.

The criticism will likely feature prominently when she appears before the Senate Health, Education, Labor and Pensions Committee.

Makary, Overton’s predecessor and a former Johns Hopkins colleague, was confirmed in March 2025 by a 56-44 Senate vote. Overton will seek confirmation from a chamber still controlled by Republicans but divided over the administration’s vaccine policies.

Her nomination signals that Trump wants the FDA led by someone already embedded in his White House rather than an agency insider or pharmaceutical executive.

If the Senate agrees, Overton will take control of one of the federal government’s most powerful scientific agencies — and become responsible for turning the administration’s sprawling health agenda into enforceable policy.

Justice Department Opens Investigation Into Former Gov. Andrew Cuomo

Photos from the opening of the new Delta Air Lines terminal in LaGuardia Airport in Queens, NY, on Tuesday, Oct. 29, 2019. (Chris Rank for Rank Studios) (Photos from the opening of the new Delta Air Lines terminal in LaGuardia Airport in Queens, NY, o

The U.S. Department of Justice has opened a criminal investigation into former New York Gov. Andrew Cuomo for allegedly lying to Congress about his decisions made during the COVID-19 pandemic while serving as governor, a source familiar with the probe confirmed to Fox News.

The New York Times first reported that the U.S. attorney’s office in Washington opened the inquiry into Cuomo about a month ago after senior officials in the DOJ demanded an indictment of New York City Mayor Eric Adams for corruption charges be dismissed.

Cuomo is running in the Democratic primary to serve as the next mayor of New York City, while Adams is seeking re-election as an independent candidate.

“We have never been informed of any such matter, so why would someone leak it now? The answer is obvious: This is lawfare and election interference plain and simple—something President Trump and his top Department of Justice officials say they are against,” Rich Azzopardi, Cuomo’s spokesperson told Fox News. “Governor Cuomo testified truthfully to the best of his recollection about events from four years earlier, and he offered to address any follow-up questions from the Subcommittee — but from the beginning this was all transparently political.”

Last year, Republican lawmakers questioned Cuomo about his handling of the COVID-19 pandemic. House Republicans subsequently recommended the Justice Department pursue criminal charges against him. They accused him of intentionally lying to Congress during the House Oversight Committee’s investigation into the excessive number of nursing home deaths.

House Oversight and Government Reform Committee Chair James Comer (R-Ky.) referred Cuomo to President Donald Trump’s Justice Department for criminal prosecution. 

Cuomo, who was governor at the time, issued a March 2020 directive that initially barred nursing homes from refusing to accept patients who had tested positive for COVID-19. The directive was aimed at freeing up beds for overwhelmed hospitals. 

More than 9,000 recovering coronavirus patients were released from hospitals into nursing homes under the directive, which was later rescinded amid speculation that it had accelerated outbreaks. Cuomo has previously said that the directive was based on the Centers for Disease Control and Prevention (CDC) and Centers for Medicare and Medicaid Services (CMS) guidance at the time.

A report released in March 2022 by the New York state comptroller found Cuomo’s Health Department “was not transparent in its reporting of COVID-19 deaths in nursing homes” and it “understated the number of deaths at nursing homes by as much as 50%” during some points of the pandemic. 

In a letter to Attorney General Pam Bondi last month, Comer said, “to our knowledge, the Biden Administration ignored this referral despite clear facts and evidence.” He requested that Bondi review the referral and “take appropriate action.” 

“Andrew Cuomo is a man with a history of corruption and deceit, now caught red-handed lying to Congress during the Select Subcommittee’s investigation into the COVID-19 nursing home tragedy in New York,” Comer said in a statement Monday. “This wasn’t a slip-up – it was a calculated cover-up by a man seeking to shield himself from responsibility for the devastating loss of life in New York’s nursing homes. Let’s be clear: lying to Congress is a federal crime. Mr. Cuomo must be prosecuted to the fullest extent of the law. The House Oversight Committee is prepared to fully cooperate with the Justice Department’s investigation into Andrew Cuomo’s actions and ensure he’s held to account.” 

Trump Aide Faints On Stage During Republican Gala

1
Photo via Pixabay images

An adviser to President-elect Trump’s campaign, Alex Bruesewitz, passed out and collapsed as he was speaking onstage during a New York Young Republican Club gala Sunday night.

Alex Bruesewitz, 27, was introducing incoming White House senior aide Dan Scavino inside a venue in Manhattan when he began stumbling over his words and fainted, video on social media shows.

Watch:

Several people quickly rushed to help after his collapse. It was not immediately clear what caused him to faint.

“I talked to our friend Alex Bruesewitz and you know what he said to me? He goes ‘Did I at least look cool?’ I said Alex, you used gravity like I’ve seen nobody use gravity before in their lives,” Kassam said. “But he’s recuperating back there, so give him a big cheer so he’ll hear you.”

Trump also said following the collapse that he believes Bruesewitz will be fine, according to the New York Post.

“I know that Alex is going to be fine because he’s a tough son of a gun,” Trump said. “There’s no doubt about that. So I want to say hello to Alex, because he’s a very special guy.”

Bruesewitz is the CEO of consultancy firm X Strategies LLC, which states its mission to help elect “America First” candidates. Its website says he is “a prominent political consultant and strategist known for his unwavering support of President Donald Trump and the America First agenda.”

Before his collapse, Bruesewitz commended the New York Republican Club for backing Trump’s campaign. He also gave shout-outs to several supporters of the incoming president who were at the event, including former Florida congressman Matt Gaetz, who recently resigned from his U.S. House seat.

Media Buzzes Over Trump’s Appearance – But Health Remains Strong, White House Says

Gage Skidmore from Surprise, AZ, United States of America, CC BY-SA 2.0 , via Wikimedia Commons

President Donald Trump set off another round of social media speculation Friday after cameras caught what looked like copious amounts of makeup on his hand during public appearances in Washington.

A patch of foundation, slightly lighter than his skin tone, was visible while he toured an exhibit at The People’s House museum. Later that day, during the World Cup 2026 draw event at The Kennedy Center, Trump kept one hand over the other while addressing the crowd — a move that didn’t go unnoticed by outlets like The Daily Beast, which pointed out the recurring appearance of cosmetic cover.

This isn’t the first time similar images have made the rounds. Observers cited previous instances following Trump’s meetings with French President Emmanuel Macron in February, European Commission President Ursula von der Leyen in July, and U.K. Prime Minister Keir Starmer.

Asked about the chatter, White House Press Secretary Karoline Leavitt brushed aside the tabloid-style coverage.

“President Trump is a man of the people, and he meets more Americans and shakes more hands on a daily basis than any other president in history,” Leavitt told The Independent Saturday. “His commitment is unwavering, and he proves that every single day.”

The renewed scrutiny follows last month’s stir over photos showing discoloration and swelling in Trump’s legs during a FIFA Club World Cup appearance. The White House later confirmed the president has chronic venous insufficiency — a common circulatory condition in which blood pools in the veins due to weakened valves.

According to the Cleveland Clinic, the condition can lead to discomfort but is manageable. Leavitt said Trump isn’t in pain and hasn’t required treatment or changes to his daily routine.

In April, White House physician Capt. Sean Barbabella declared the president in “excellent cognitive and physical health” after his annual checkup. He attributed bruising on Trump’s hands to aspirin therapy, a standard precaution for heart health.

Leavitt emphasized that the president’s physician remains available to answer any medical questions and insisted, “There is nothing to hide.”

READ NEXT: Former Trump Ally Issues Fiery Response To Shock Report